In this study, CEA had a detection sensitivity of 35.71% and sensitivity 78.57%, and patients in stage III, IV, and lymph node metastasis had a higher CEA positive rate, showing that CEA expression was possibly related to the staging and lymph node metastasis. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.